Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PATISIRAN vs PEGASPARGASE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PATISIRAN vs PEGASPARGASE: Safety Overview

Metric PATISIRAN PEGASPARGASE
Total FAERS Reports 2,708 11,543
Deaths Reported 384 1,555
Death Rate 14.2% 13.5%
Hospitalizations 1,050 6,990
Average Patient Age 65.6 yrs 15.4 yrs
% Female Patients 34.2% 42.8%
FDA Approval Date Aug 10, 2018 N/A
Manufacturer Alnylam Pharmaceuticals, Inc. Servier Pharmaceuticals LLC
Route INTRAVENOUS INTRAMUSCULAR
Marketing Status Prescription Prescription